Variation in Treatment of Patients With Inflammatory Bowel Diseases at Major Referral Centers in the United States

Ashwin N. Ananthakrishnan, Jennifer Kwon, Laura E. H. Raffals, Bruce Sands, William F. Stenson, Dermot McGovern, John H. Kwon, Robert L. Rheaume, Robert S. Sandler

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We performed a prospective study of patients with inflammatory bowel diseases to examine variations in treatment among medical centers. In a prospective cohort study of 1659 patients with Crohn's disease and 946 patients with ulcerative colitis seen at 7 high-volume referral centers, we collected data on demographics, disease characteristics, and medical and surgical treatments. We used logistic regression to determine differences in treatment among centers, controlling for potential confounders. We found significant variations among centers in the treatment of Crohn's disease with immunomodulators (odds ratio [OR], 3.34; 95% confidence interval [CI], 2.09-5.32) but not anti-tumor necrosis factor agents (OR, 1.64; 95% CI, 0.97-2.77). There was less variation in the treatment of ulcerative colitis; we found no difference in use of immunomodulators (OR, 1.83; 95% CI, 1.00-3.36) or anti-tumor necrosis factor therapy (OR, 0.81; 95% CI, 0.40-1.65). The development and implementation of evidence-based standards of care for inflammatory bowel disease may help reduce variation and improve outcomes.

Original languageEnglish (US)
Pages (from-to)1197-1200
Number of pages4
JournalClinical Gastroenterology and Hepatology
Volume13
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Inflammatory Bowel Diseases
Referral and Consultation
Odds Ratio
Confidence Intervals
Immunologic Factors
Ulcerative Colitis
Crohn Disease
Therapeutics
Tumor Necrosis Factor-alpha
Prospective Studies
Standard of Care
Cohort Studies
Logistic Models
Demography

Keywords

  • Anti-TNF Agent
  • IBD
  • Practice Variation
  • Sinai Helmsley Alliance for Research Excellence (SHARE) Consortium

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Variation in Treatment of Patients With Inflammatory Bowel Diseases at Major Referral Centers in the United States. / Ananthakrishnan, Ashwin N.; Kwon, Jennifer; Raffals, Laura E. H.; Sands, Bruce; Stenson, William F.; McGovern, Dermot; Kwon, John H.; Rheaume, Robert L.; Sandler, Robert S.

In: Clinical Gastroenterology and Hepatology, Vol. 13, No. 6, 01.06.2015, p. 1197-1200.

Research output: Contribution to journalArticle

Ananthakrishnan, AN, Kwon, J, Raffals, LEH, Sands, B, Stenson, WF, McGovern, D, Kwon, JH, Rheaume, RL & Sandler, RS 2015, 'Variation in Treatment of Patients With Inflammatory Bowel Diseases at Major Referral Centers in the United States', Clinical Gastroenterology and Hepatology, vol. 13, no. 6, pp. 1197-1200. https://doi.org/10.1016/j.cgh.2014.11.020
Ananthakrishnan, Ashwin N. ; Kwon, Jennifer ; Raffals, Laura E. H. ; Sands, Bruce ; Stenson, William F. ; McGovern, Dermot ; Kwon, John H. ; Rheaume, Robert L. ; Sandler, Robert S. / Variation in Treatment of Patients With Inflammatory Bowel Diseases at Major Referral Centers in the United States. In: Clinical Gastroenterology and Hepatology. 2015 ; Vol. 13, No. 6. pp. 1197-1200.
@article{5d5ca181e7534dd489fcf0ebbb4a93e5,
title = "Variation in Treatment of Patients With Inflammatory Bowel Diseases at Major Referral Centers in the United States",
abstract = "We performed a prospective study of patients with inflammatory bowel diseases to examine variations in treatment among medical centers. In a prospective cohort study of 1659 patients with Crohn's disease and 946 patients with ulcerative colitis seen at 7 high-volume referral centers, we collected data on demographics, disease characteristics, and medical and surgical treatments. We used logistic regression to determine differences in treatment among centers, controlling for potential confounders. We found significant variations among centers in the treatment of Crohn's disease with immunomodulators (odds ratio [OR], 3.34; 95{\%} confidence interval [CI], 2.09-5.32) but not anti-tumor necrosis factor agents (OR, 1.64; 95{\%} CI, 0.97-2.77). There was less variation in the treatment of ulcerative colitis; we found no difference in use of immunomodulators (OR, 1.83; 95{\%} CI, 1.00-3.36) or anti-tumor necrosis factor therapy (OR, 0.81; 95{\%} CI, 0.40-1.65). The development and implementation of evidence-based standards of care for inflammatory bowel disease may help reduce variation and improve outcomes.",
keywords = "Anti-TNF Agent, IBD, Practice Variation, Sinai Helmsley Alliance for Research Excellence (SHARE) Consortium",
author = "Ananthakrishnan, {Ashwin N.} and Jennifer Kwon and Raffals, {Laura E. H.} and Bruce Sands and Stenson, {William F.} and Dermot McGovern and Kwon, {John H.} and Rheaume, {Robert L.} and Sandler, {Robert S.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.cgh.2014.11.020",
language = "English (US)",
volume = "13",
pages = "1197--1200",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Variation in Treatment of Patients With Inflammatory Bowel Diseases at Major Referral Centers in the United States

AU - Ananthakrishnan, Ashwin N.

AU - Kwon, Jennifer

AU - Raffals, Laura E. H.

AU - Sands, Bruce

AU - Stenson, William F.

AU - McGovern, Dermot

AU - Kwon, John H.

AU - Rheaume, Robert L.

AU - Sandler, Robert S.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - We performed a prospective study of patients with inflammatory bowel diseases to examine variations in treatment among medical centers. In a prospective cohort study of 1659 patients with Crohn's disease and 946 patients with ulcerative colitis seen at 7 high-volume referral centers, we collected data on demographics, disease characteristics, and medical and surgical treatments. We used logistic regression to determine differences in treatment among centers, controlling for potential confounders. We found significant variations among centers in the treatment of Crohn's disease with immunomodulators (odds ratio [OR], 3.34; 95% confidence interval [CI], 2.09-5.32) but not anti-tumor necrosis factor agents (OR, 1.64; 95% CI, 0.97-2.77). There was less variation in the treatment of ulcerative colitis; we found no difference in use of immunomodulators (OR, 1.83; 95% CI, 1.00-3.36) or anti-tumor necrosis factor therapy (OR, 0.81; 95% CI, 0.40-1.65). The development and implementation of evidence-based standards of care for inflammatory bowel disease may help reduce variation and improve outcomes.

AB - We performed a prospective study of patients with inflammatory bowel diseases to examine variations in treatment among medical centers. In a prospective cohort study of 1659 patients with Crohn's disease and 946 patients with ulcerative colitis seen at 7 high-volume referral centers, we collected data on demographics, disease characteristics, and medical and surgical treatments. We used logistic regression to determine differences in treatment among centers, controlling for potential confounders. We found significant variations among centers in the treatment of Crohn's disease with immunomodulators (odds ratio [OR], 3.34; 95% confidence interval [CI], 2.09-5.32) but not anti-tumor necrosis factor agents (OR, 1.64; 95% CI, 0.97-2.77). There was less variation in the treatment of ulcerative colitis; we found no difference in use of immunomodulators (OR, 1.83; 95% CI, 1.00-3.36) or anti-tumor necrosis factor therapy (OR, 0.81; 95% CI, 0.40-1.65). The development and implementation of evidence-based standards of care for inflammatory bowel disease may help reduce variation and improve outcomes.

KW - Anti-TNF Agent

KW - IBD

KW - Practice Variation

KW - Sinai Helmsley Alliance for Research Excellence (SHARE) Consortium

UR - http://www.scopus.com/inward/record.url?scp=84930375398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930375398&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2014.11.020

DO - 10.1016/j.cgh.2014.11.020

M3 - Article

C2 - 25460565

AN - SCOPUS:84930375398

VL - 13

SP - 1197

EP - 1200

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 6

ER -